Melanoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
  • Melanoma
  • Intervention Arm
  • Standard diet and exercise
  • Loma Linda, California
  • +1 more
2022-04-07
Apr 7, 2022
P
Recruiting
  • Oncology
  • +9 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +2 more
2022-04-07
Apr 7, 2022
N
Enrolling by invitation
  • Melanoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    C
    Recruiting
    • Melanoma
    • +3 more
    • Phoenix, Arizona
    • +24 more
    2022-04-06
    Apr 6, 2022
    N
    Recruiting
    • Pancreatic Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Enrolling by invitation
    • Melanoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      N
      Active, not recruiting
      • Retinoblastoma
      • +2 more
        • Bethesda, Maryland
          National Cancer Institute (NCI), 9000 Rockville Pike
        2022-04-07
        Apr 7, 2022
        N
        Completed
        • Gastrointestinal Cancer
        • +3 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-04-07
          Apr 7, 2022
          N
          Active, not recruiting
          • Prostate Cancer
          • +4 more
            • Bethesda, Maryland
              National Cancer Institute (NCI), 9000 Rockville Pike
            2022-04-07
            Apr 7, 2022
            N
            Recruiting
            • Xeroderma Pigmentosum
            • +4 more
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              2022-04-07
              Apr 7, 2022
              H
              Recruiting
              • Gastric Cancer
              • +8 more
              • Los Angeles, California
              • +2 more
              2022-04-05
              Apr 5, 2022
              I
              Completed
              • Melanoma
              • London, United Kingdom
              • +1 more
              2022-04-06
              Apr 6, 2022
              R
              Completed
              • Dysplastic Nevus
              • +3 more
              • Best Practice
              • +2 more
              • New Brunswick, New Jersey
                Rutgers Cancer Institute of New Jersey
              2022-04-05
              Apr 5, 2022
              M
              Active, not recruiting
              • Melanoma Stage Iv
              • +2 more
              • Albury, New South Wales, Australia
              • +9 more
              2022-04-06
              Apr 6, 2022
              N
              Recruiting
              • Pancreatic Cancer
              • +15 more
              • Grand Rapids, Michigan
              • +2 more
              2022-04-05
              Apr 5, 2022
              M
              Active, not recruiting
              • Melanoma
              • Sydney, New South Wales, Australia
              • +2 more
              2022-04-04
              Apr 4, 2022
              D
              Recruiting
              • Liver Metastases
              • +10 more
              • DNX-2440
              • Tampa, Florida
                H. Lee Moffitt Cancer Center and Research Institute, Inc.
              2022-03-28
              Mar 28, 2022
              S
              Completed
              • Acute Myeloid Leukemia
              • +8 more
              • DSP-7888 Dosing Emulsion
              • Denver, Colorado
              • +7 more
              2022-04-04
              Apr 4, 2022
              M
              Recruiting
              • Melanoma
              • Melanoma Stage III
              • PET Scan
              • +3 more
              • New York, New York
                Memorial Sloan Kettering Cancer Center (All Protocol Activities)
              2022-04-04
              Apr 4, 2022